Target intelligence / Profile preview

Protein phosphatase 2 catalytic subunit alpha divergent transcript (PPP2CA-DT)

Target
PPP2CA-DT
01

Overview

PPP2CA-DT appears to reference a transcript variant from the *PPP2CA* gene, which encodes the catalytic alpha subunit of protein phosphatase 2A, a crucial enzyme in cell signaling, division, and apoptosis[1][2]. There is no robust published evidence describing PPP2CA-DT as a distinct molecular target, therapeutic entity, or receptor; scientific literature focuses on the canonical protein and its functional roles as an enzyme and tumor suppressor. Transcript variants of *PPP2CA* are not well-characterized as separate drug targets. The reference to "divergent transcript" may be misapplied, overly generic, or stemming from unclear data annotation. If you require information on the canonical *PPP2CA*-encoded enzyme rather than its divergent transcripts, please specify; full details and classifications are available for Protein Phosphatase 2A catalytic subunit alpha. Otherwise, current sources do not support PPP2CA-DT as a valid, actionable, or characterized drug target[1][2].

Other names
Protein phosphatase 2 catalytic subunit alpha (for canonical protein/gene)PPP2CA (parent gene/protein)PP2A-Cα (canonical protein subunit)
02

Mechanism of action

Null (no drugs known to target PPP2CA-DT)

03

Biological functions

Null
04

Disease associations

Null
05

Safety considerations

Null
06

Interacting drugs

Null
07

Biomarkers

Null

Beyond the preview

Go deeper on Protein phosphatase 2 catalytic subunit alpha divergent transcript (PPP2CA-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein phosphatase 2 catalytic subunit alpha divergent transcript (PPP2CA-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call